Journal of Current Glaucoma Practice

Register      Login

VOLUME 16 , ISSUE 2 ( May-August, 2022 ) > List of Articles


Efficacy and Safety of iStent Inject Implantation in Manual and Femtosecond Laser-assisted Cataract Surgery before Lens Extraction

David Kevin Manning, Ali Haider, Colin Clement, Deepa Viswanathan

Keywords : Femtosecond laser-assisted cataract surgery, Glaucoma, iStent, Microinvasive glaucoma surgery

Citation Information : Manning DK, Haider A, Clement C, Viswanathan D. Efficacy and Safety of iStent Inject Implantation in Manual and Femtosecond Laser-assisted Cataract Surgery before Lens Extraction. J Curr Glaucoma Pract 2022; 16 (2):105-110.

DOI: 10.5005/jp-journals-10078-1374

License: CC BY-NC 4.0

Published Online: 30-08-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Aim: To describe the efficacy and safety of iStent implantation prior to phacoemulsification in manual as well as femtosecond laser-assisted cataract surgery (FLACS), and highlight this approach as a reasonable, if not necessary, step to advance one's ability and confidence in the use of microinvasive glaucoma surgery (MIGS) technology in phakic patients. Methods: A retrospective consecutive case series of patients with open angle glaucoma or ocular hypertension who underwent iStent inject implantation followed by cataract surgery (manual or FLACS). All cases underwent postoperative video review and were assessed and classified for intraoperative lens injury and hyphaema. Postoperative data included intraocular pressure (IOP), medication usage and adverse events. Results: Sixty-three eyes (n = 40 manual, n = 23 FLACS) were analyzed. Preoperatively, the mean IOP was 19.2 ± 4.9 mm Hg on 1.4 ± 0.96 mean medications, with 100% of eyes treated with medication. Intraoperatively, no lens injury was identified, and no significant hyphaema that impeded surgery occurred. At 6 months postoperative, mean IOP was 14.2 ± 1.8 mm Hg (38% reduction: p < 0.001), and >90% of eyes had IOP ≤ 16 mm Hg. The mean number of medications reduced to 0.11 ± 0.3 (92% reduction: p < 0.001), with 89% of eyes medication free. Safety was excellent for both manual and FLACS, with two iStents implanted in all eyes, and no cases of significant hyphaema or lens injury. Conclusion: Early implantation is safe, maximizes corneal clarity and angle visualization, avoids the risk of non-implantation due to surgical complications, and has a high success rate in both manual cataract surgery and the setting of FLACS. Clinical significance: The conventional recommended approach of iStent implantation following cataract extraction has been adopted by many, however, with the advent of stand-alone procedures and concern about potential lens injury, there is an opportunity to gain experience with minimal risk in patients undergoing MIGS procedures combined with cataract surgery by implanting iStents at the start of the procedure. There is currently little emphasis or data published in the literature on an early approach to implantation to guide surgeons.

PDF Share
  1. Gallardo MJ, Supnet RA, Giamporcaro JE, et al. Outcomes of combined trabecular micro-bypass and phacoemulsification in a predominantly Hispanic patient population. Clin Ophthalmol 2016;10:1931–1937. DOI: 10.2147/opth.s117403
  2. Arriola-Villalobos P, Martinez-de-la-Casa JM, Diaz-Valle D, et al. Glaukos iStent inject® trabecular micro-bypass implantation associated with cataract surgery in patients with coexisting cataract and open-angle glaucoma or ocular hypertension: a long-term study. J Ophthalmology 2016:1056573. DOI: 10.1155/2016/1056573
  3. Epstein RS, Scott AT, Young CEC, et al. Optimum time for angle visualization during ab interno glaucoma surgery: before or after phacoemulsification. J Cataract Refract Surg 2019;45(5):615–619. DOI: 10.1016/j.jcrs.2019.01.012
  4. Richter GM, Coleman AL. Minimally invasive glaucoma surgery: current status and future prospects. Clin Ophthalmology 2016;10:189–206. DOI: 10.2147/OPTH.S80490
  5. Samuelson TW, Katz LJ, Wells JM, et al. Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract. Ophthalmology 2011;118(3):459–467. DOI: 10.1016/j.ophtha.2010.07.007
  6. Fernandez-Barrientos Y, Garcia-Feijoo J, Martinez-de-la-Casa JM, et al. Fluorophotometric study of the effect of the glaukos trabecular microbypass stent on aqueous humor dynamics. Invest Ophthalmol Vis Sci. 2010;51(7):3327–3332. DOI: 10.1167/iovs.09-3972
  7. Resende AF, Patel NS, Waisbourd M, et al. iStent® trabecular microbypass stent: an update. J Ophthalmology 2016:2731856. DOI: 10.1155/2016/2731856
  8. Agarwal A, Jacob S. Current and effective advantages of femto phacoemulsification. Curr Opin Ophthalmol 2017;28(1):49–57. DOI: 10.1097/ICU.0000000000000333
  9. Khng C, Packer M, Fine IH, et al. Intraocular pressure during phacoemulsification. J Cataract Refract Surg 2006;32(2):301–308. DOI: 10.1016/j.jcrs.2005.08.062
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.